Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN – Get Free Report) have earned a consensus recommendation of “Hold” from the eleven brokerages that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, six have given a hold rating and four have issued a buy rating on the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $59.00.
A number of brokerages have recently commented on RYAN. Wells Fargo & Company upped their target price on Ryan Specialty from $60.00 to $63.00 and gave the stock an “equal weight” rating in a research note on Friday. Bank of America began coverage on Ryan Specialty in a research note on Wednesday, May 22nd. They issued a “buy” rating and a $67.00 target price on the stock. JPMorgan Chase & Co. upped their target price on Ryan Specialty from $54.00 to $56.00 and gave the stock an “underweight” rating in a research note on Friday. Keefe, Bruyette & Woods reaffirmed an “outperform” rating and issued a $62.00 price target on shares of Ryan Specialty in a report on Tuesday, July 2nd. Finally, JMP Securities reaffirmed a “market perform” rating on shares of Ryan Specialty in a report on Monday, April 15th.
Check Out Our Latest Stock Analysis on RYAN
Ryan Specialty Stock Up 9.7 %
Ryan Specialty (NYSE:RYAN – Get Free Report) last issued its earnings results on Thursday, August 1st. The company reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.01. Ryan Specialty had a return on equity of 45.87% and a net margin of 9.15%. The firm had revenue of $695.40 million for the quarter, compared to the consensus estimate of $695.56 million. During the same quarter in the prior year, the business earned $0.45 earnings per share. The company’s revenue was up 18.9% compared to the same quarter last year. Equities analysts anticipate that Ryan Specialty will post 1.77 EPS for the current year.
Institutional Inflows and Outflows
Institutional investors have recently modified their holdings of the stock. GAMMA Investing LLC lifted its holdings in Ryan Specialty by 96.4% in the second quarter. GAMMA Investing LLC now owns 605 shares of the company’s stock valued at $35,000 after acquiring an additional 297 shares during the last quarter. Crewe Advisors LLC purchased a new stake in Ryan Specialty in the second quarter valued at approximately $39,000. Parkside Financial Bank & Trust raised its position in Ryan Specialty by 1,283.6% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,010 shares of the company’s stock valued at $43,000 after purchasing an additional 937 shares during the period. Intelligent Financial Strategies purchased a new stake in Ryan Specialty in the first quarter valued at approximately $44,000. Finally, Benjamin F. Edwards & Company Inc. purchased a new stake in Ryan Specialty in the first quarter valued at approximately $45,000. Hedge funds and other institutional investors own 84.82% of the company’s stock.
About Ryan Specialty
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Featured Articles
- Five stocks we like better than Ryan Specialty
- 3 REITs to Buy and Hold for the Long Term
- Should You Invest in Bitcoin? Pros and Cons
- Canada Bond Market Holiday: How to Invest and Trade
- Amazon Stock is Primed to Rebound Strongly After AI Bubble Bursts
- What is the S&P/TSX Index?
- Shell Stock: Oil & Gas Giant Committed to Buybacks and Dividends
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.